Cero Therapeutics Holdings CERO Balance Sheet (2021-2026)

OTC CERO
$0.00 +0.00 (+0.00%)
At close: Nov 10, 2026 · 4:00 PM EST
Reported Financials

Cero Therapeutics Holdings Quarterly Balance Sheet

Periods 20 quarters
Latest Jun 2026

Cero Therapeutics Holdings reported total assets of $0.00B and total liabilities of $0.03B for the quarter ended Jun 2026, down 69.4% year over year. This balance sheet covers 20 quarters of results from Sep 2021 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Balance SheetBalance Sheet Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Assets
Current Assets
Cash & EquivalentsCash & Equiv. 1.10M0.79M0.55M0.51M0.48M0.18M0.11M0.12M1.60M4.59M3.65M3.38M3.33M5.20M3.30M2.02M1.66M0.86M0.94M
Short-term InvestmentsInvestments (Current) 0.50M
Cash & Current Investments 1.10M0.79M0.55M0.51M0.48M0.18M0.11M0.12M1.60M4.59M3.65M3.38M3.33M5.20M3.80M2.02M1.66M0.86M0.94M
Receivables - OtherOther Receivables 0.16M0.09M
Current Deferred Tax AssetsCurrent Deferred Tax 0.05M
Prepaid Assets 0.02M0.26M0.31M0.29M0.28M0.23M0.22M0.11M0.02M0.37M0.75M0.51M0.33M0.27M0.56M0.44M0.53M1.07M0.72M0.61M
Current Assets 0.02M1.36M1.10M0.85M0.79M42.37M1.97M5.50M4.25M3.71M3.71M5.77M4.25M2.55M2.73M1.57M1.55M
Non-Current Assets
Property, Plant & Equipment (Net)PP&E (Net) 0.97M0.85M0.74M0.62M0.53M0.45M0.38M0.31M0.25M0.18M0.13M
Long-Term Investments 178.50M178.53M178.79M179.64M41.67M0.10M0.15M8.33M0.02M
Long-Term Deferred Tax 0.02M
Other Non-Current Assets 0.28M0.20M0.15M0.09M0.02M41.67M0.04M0.08M0.68M0.55M0.50M0.57M0.50M0.07M0.25M0.07M0.07M0.07M
Non-Current Assets 0.28M178.72M178.68M178.88M179.67M3.16M3.55M3.12M2.78M2.49M2.22M1.96M1.36M0.91M0.63M0.35M
Assets 0.30M180.08M179.78M179.72M180.45M42.37M14.43M14.11M8.47M5.13M9.05M7.37M6.49M6.21M7.99M6.20M3.91M3.64M2.21M1.90M
Liabilities
Current Liabilities
Accounts Payables 0.00M0.01M0.12M0.16M0.71M1.65M2.02M3.15M3.31M1.67M7.06M6.35M6.67M4.51M6.38M6.21M7.08M7.58M7.69M8.22M
Notes Payables 0.65M0.65M1.18M1.40M0.60M0.40M0.25M0.10M0.75M
Dividends payables 0.09M0.09M0.09M0.09M0.09M0.09M0.09M
Payables 0.00M0.01M0.12M0.16M0.71M2.30M2.67M4.32M4.71M2.27M7.46M6.60M6.77M4.59M6.46M6.30M7.16M7.67M7.77M9.05M
Accumulated Expenses 0.28M0.14M0.29M1.16M1.69M1.91M0.47M0.37M0.34M0.36M0.50M0.49M
Other Accumulated Expenses 0.08M0.05M0.07M0.10M0.00M0.02M0.02M0.01M0.03M0.03M0.03M0.59M0.28M0.14M0.09M692.00692.00692.00
Short term Debt 13,723,000.00M
Current Leases 0.34M0.20M0.01M
Current Taxes 0.06M0.60M0.60M0.07M0.03M0.02M0.08M0.09M0.08M0.08M0.08M0.08M6.19M
Total Current Liabilities 0.28M0.10M0.17M0.23M0.88M30.75M3.29M4.41M4.80M3.51M11.65M8.78M9.42M7.40M7.86M7.62M8.45M9.09M11.33M32.41M
Non-Current Liabilities
Convertible Debt 0.14M0.75M
Non-Current Deferred Revenue 9.15M9.15M9.15M9.15M9.15M9.15M9.15M9.15M9.15M
Preferred Stock Liabilities 178.50M178.50M178.50M179.48M13.47M13.57M13.84M8.29M8.44M14.97M
Operating Leases 1.58M1.37M1.07M0.77M0.70M0.46M0.22M0.93M0.70M0.46M0.22M
Other Non-Current Liabilities 0.61M0.65M0.32M3.10M0.20M0.03M0.02M0.02M0.02M0.02M0.02M0.90M500.00
Total Non-Current Liabilities 0.28M187.75M52.76M25.36M46.86M-45,707.73M-38.54M-39.25M8.08M8.30M7.82M8.43M9.07M10.57M32.40M
Total Liabilities 0.28M187.75M187.82M187.88M189.51M53.37M26.01M27.40M22.24M47.18M-45,704.63M-38.34M-39.22M8.10M8.32M7.84M8.45M9.09M11.46M32.41M
Shareholder's Equity
Total Debt 0.65M0.65M1.18M1.40M0.60M13,723,000.40M0.25M0.10M0.75M
Common Equity 0.02M-7.67M-8.05M-8.16M-9.06M-11.00M-11.58M-13.29M-13.77M-42.06M45,713.69M45.71M45.71M-1.89M-0.33M-1.63M-4.54M-5.45M-9.26M-30.51M
Liabilities and Shareholders Equity 0.30M180.08M179.78M179.72M180.45M42.37M14.43M14.11M8.47M5.13M9.05M7.37M6.49M6.21M7.99M6.20M3.91M3.64M2.21M1.90M
Treasury Stock -2,500,000,000.00M-2,194,971,000.00M-2,073,607,000.00M-1.30M-0.08M-0.08M-0.04M-0.01M
Retained Earnings 0.00M-7.67M-8.05M-8.16M-9.06M-11.00M-11.58M-13.29M-13.77M-43.09M-64.91M-67.36M-71.59M-70.92M-76.02M-81.44M-86.30M-90.84M-96.72M-97.80M
Preferred Shares 9.44M9.44M3.58M3.18M2.43M500,000.00M8.70M7.26M7.22M14.97M

Cero Therapeutics Holdings Balance Sheet API

Pull Cero Therapeutics Holdings's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=CERO&statement=BS&frequency=Quarter&period=all&api_key=YOUR_API_KEY